Maximising recruitment into randomised controlled trials: The role of multidisciplinary cancer teams

Angus G K Mcnair, CT Choh, C Metcalfe, D Littlejohns, CP Barham, AD Hollowood, S Falk, JM Blazeby

Research output: Contribution to journalArticle (Academic Journal)peer-review

40 Citations (Scopus)

Abstract

Multidisciplinary cancer teams offer many theoretical benefits, although few have been formally examined. This study evaluated the role of multidisciplinary team (MDT) meetings in recruitment into randomised controlled trials (RCTs). Consecutive MDT patient records were categorised into those with or without a recommendation for a national multicentre RCT. Clinical trial office records identified whether patients were subsequently screened and randomised. In 125 MDT meetings, 350 new patients were discussed, of whom 103 were potentially suitable for a RCT. The MDT recommended 68 patients for the trial, of whom 58 (85%) were screened for trial eligibility. Of the 35 without an MDT trial recommendation, only 23 (66%) were screened (p=0.022). This difference persisted and resulted in a greater proportion of MDT recommended patients being recruited (65% versus 49%; p=0.12). This study demonstrates that trial recommendation by an MDT significantly increases trial screening rates and may improve recruitment.
Translated title of the contributionMaximising recruitment into randomised controlled trials: The role of multidisciplinary cancer teams
Original languageEnglish
Pages (from-to)2623 - 2626
Number of pages4
JournalEuropean Journal of Cancer
Volume44(17)
DOIs
Publication statusPublished - Nov 2008

Bibliographical note

Publisher: Elsevier
Other: Pub Med ID 18804999

Fingerprint Dive into the research topics of 'Maximising recruitment into randomised controlled trials: The role of multidisciplinary cancer teams'. Together they form a unique fingerprint.

Cite this